MiRNA-26a promotes angiogenesis in a rat model of cerebral infarction via PI3K/AKT and MAPK/ERK pathway

Z Liang1, Y-J Chi, G-Q Lin

  • 1Department of Neurosurgery, Lianjiang Hospital Affiliated To Guangdong Medical University/Lianjiang People's Hospital, Lianjiang, China. liangzaizai008@163.com.

Abstract

Insights

MicroRNA-26a promotes blood vessel formation in rats after ischemic stroke. It activates signaling pathways to enhance cell growth and repair, aiding recovery from brain injury.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Cerebral ischemic stroke remains a leading cause of disability.
  • Understanding the molecular mechanisms of angiogenesis is crucial for developing effective treatments.
  • MicroRNAs play significant roles in regulating cellular processes relevant to stroke recovery.

Purpose of the Study:

  • To investigate the specific role of microRNA-26a (miRNA-26a) in a rat model of cerebral ischemic stroke.
  • To elucidate the underlying molecular mechanisms by which miRNA-26a influences angiogenesis and cell proliferation.

Main Methods:

  • Established a rat model of middle cerebral artery occlusion (MCAO) to induce cerebral infarction.
  • Quantified miRNA-26a expression using qPCR in brain tissue and brain microvascular endothelial cells (BMECs).
  • Assessed endothelial lumen formation, cell proliferation (MTT assay), and signaling pathway activation (Western blot for PI3K/AKT and MAPK/ERK).

Main Results:

  • miRNA-26a expression was significantly elevated following cerebral infarction.
  • miRNA-26a mimics promoted endothelial lumen formation and BMEC proliferation, while inhibitors reduced these effects.
  • miRNA-26a was found to up-regulate HIF-1a via the AKT and ERK1/2 pathways, subsequently promoting VEGF transcription.

Conclusions:

  • miRNA-26a plays a critical role in promoting angiogenesis post-cerebral ischemic stroke.
  • The pro-angiogenic effects of miRNA-26a are mediated through the PI3K/AKT and MAPK/ERK signaling pathways.
  • Targeting miRNA-26a may represent a therapeutic strategy for enhancing recovery after ischemic stroke.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.5K
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
2.2K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.9K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

4.0K
Models of Health Promotion and Illness Prevention I01:25

Models of Health Promotion and Illness Prevention I

A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
2.9K